Assignee profile:

EUTROPICS PHARMACEUTICALS, INC.

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

14

Last publication date:

2020-12-17

Patent Grants:

12

Last grant date:

2023-05-23

Top Inventors for applications by EUTROPICS PHARMACEUTICALS, INC.

These are the the leading inventors for applications assigned to EUTROPICS PHARMACEUTICALS, INC.:

Recent patent applications by EUTROPICS PHARMACEUTICALS, INC.

EUTROPICS PHARMACEUTICALS, INC. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-12-17 ✅ Patent 11,656,230 granted on 2023-05-23
US20200393468A1
Physics

Method for predicting cancer sensitivity

#2 | 2018-11-29 ✅ Patent 10,793,915 granted on 2020-10-06
US20180340229A1
Chemistry; metallurgy

Context dependent diagnostics test for guiding cancer treatment

#3 | 2018-08-09 ✅ Patent 10,765,673 granted on 2020-09-08
US20180221366A1
Human necessities

Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivatives

#4 | 2018-07-26 ✅ Patent 10,413,549 granted on 2019-09-17
US20180207170A1
Human necessities

Methods and compositions useful for treating diseases involving Bcl-2 family proteins with isoquinoline and quinoline derivatives

#5 | 2016-09-22 ✅ Patent 10,640,803 granted on 2020-05-05
US20160273020A1
Chemistry; metallurgy

Methods for determining chemosensitivity and chemotoxicity

#6 | 2016-06-23 ✅ Patent 10,732,182 granted on 2020-08-04
US20160178634A1
Physics

Method for predicting cancer sensitivity

#7 | 2015-12-10 ✅ Patent 9,345,700 granted on 2016-05-24
US20150352097A1
Human necessities

Compositions and methods useful for treating diseases

#8 | 2015-08-06 ✅ Patent 9,351,971 granted on 2016-05-31
US20150216862A1
Human necessities

Substituted 2,2′-biphenazines for treating diseases

#9 | 2014-08-21
US20140234867A1
Chemistry; metallurgy

Antibodies Specific to Heterodimers of Bcl-2 Family and Uses Thereof

#10 | 2014-08-07 ✅ Patent 9,051,305 granted on 2015-06-09
US20140221387A1
Chemistry; metallurgy

Compositions and methods useful for treating diseases

#11 | 2012-09-06 ✅ Patent 8,987,271 granted on 2015-03-24
US20120225851A1
Human necessities

2,2′-biphenazine compounds and methods useful for treating disease

#12 | 2012-09-06
US20120225794A1
Chemistry; metallurgy

Antibodies Specific to Heterodimers of Bcl-2 Family and Uses Thereof

#13 | 2011-06-02 ✅ Patent 9,360,473 granted on 2016-06-07
US20110130309A1
Physics

Assay system to identify therapeutic agents

#14 | 2009-11-12 ✅ Patent 8,168,755 granted on 2012-05-01
US20090280510A1
Chemistry; metallurgy

Antibodies specific to heterodimers of Bcl-2 family and uses thereof

Also check out Eutropics Pharmaceuticals, Inc.'s (Cambridge, United States) applicant profile with 9 patent applications submitted.

AssigneeID:

73967 ⎘